ALKS vs DOW · P/E 14, rev $1.56B vs P/E 74, rev $42.96B
Alkermes Plc (ALKS) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Dow Inc (DOW) is a chemicals company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the ALKS and DOW stock pages for the full models.
Not investment advice.